Skip to main content
All lobbying filings

MCDERMOTT WILL & SCHULTE LLP

Lobbying for SURESCRIPTS · Health IT Company

 Filing 4th Quarter - Report
4th Quarter (Oct 1 - Dec 31) 2025 · Virginia · House · Senate · $30,000.00 income · posted Jan 14, 2026

Official filing document

 Lobbying activity 3
Health Issues

Efforts to promote interoperability, advance electronic prescribing of controlled substances, and ensure that technological advances in the pharmacy services sector, including in electronic prescribing and electronic prior authorization, benefit patients, prescribers, and others in a timely way.

Science/Technology

Efforts to advance interoperability and to ensure that technological advances in the pharmacy services sector, including in electronic prescribing and electronic prior authorization, benefit patients, prescribers, and others in a timely way.

Medicare/Medicaid

Efforts to advance interoperability and to ensure that technological advances in the pharmacy services sector, including in electronic prescribing and electronic prior authorization, benefit patients, prescribers, and others in a timely way. Efforts to promote equitable community access to pharmacist services.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem